| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.87e-10 | 20 | 42 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.16e-08 | 36 | 42 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 6.36e-08 | 50 | 42 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 8.57e-08 | 53 | 42 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 2.42e-05 | 279 | 42 | 6 | GO:0005096 | |
| GeneOntologyMolecularFunction | isomerase activity | 4.97e-05 | 192 | 42 | 5 | GO:0016853 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 5.71e-05 | 656 | 42 | 8 | GO:0008047 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.73e-04 | 398 | 42 | 6 | GO:0061659 | |
| GeneOntologyMolecularFunction | small GTPase binding | 5.44e-04 | 321 | 42 | 5 | GO:0031267 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 6.28e-04 | 507 | 42 | 6 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 6.28e-04 | 507 | 42 | 6 | GO:0030695 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 6.61e-04 | 512 | 42 | 6 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 8.07e-04 | 532 | 42 | 6 | GO:0016755 | |
| GeneOntologyMolecularFunction | GTPase binding | 9.11e-04 | 360 | 42 | 5 | GO:0051020 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.06e-03 | 775 | 42 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 3.72e-03 | 1233 | 42 | 8 | GO:0140677 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 4.77e-03 | 49 | 42 | 2 | GO:0004180 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 7.54e-03 | 62 | 42 | 2 | GO:0019829 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 8.55e-03 | 1418 | 42 | 8 | GO:0030234 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.02e-12 | 9 | 41 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 6.03e-12 | 10 | 41 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 3.07e-11 | 13 | 41 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 4.76e-11 | 14 | 41 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.66e-10 | 20 | 41 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.15e-08 | 38 | 41 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 7.10e-08 | 54 | 41 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 2.85e-07 | 71 | 41 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 2.65e-06 | 111 | 41 | 5 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 3.15e-06 | 115 | 41 | 5 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 4.05e-06 | 121 | 41 | 5 | GO:0046364 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 6.20e-06 | 132 | 41 | 5 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 6.67e-06 | 134 | 41 | 5 | GO:0010906 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 8.19e-06 | 244 | 41 | 6 | GO:0006006 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 9.20e-06 | 249 | 41 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | mRNA transport | 9.79e-06 | 145 | 41 | 5 | GO:0051028 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 1.94e-05 | 284 | 41 | 6 | GO:0019318 | |
| GeneOntologyBiologicalProcess | RNA transport | 2.43e-05 | 175 | 41 | 5 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 2.43e-05 | 175 | 41 | 5 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.64e-05 | 178 | 41 | 5 | GO:0051236 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 3.17e-05 | 310 | 41 | 6 | GO:0005996 | |
| GeneOntologyBiologicalProcess | nuclear export | 3.17e-05 | 185 | 41 | 5 | GO:0051168 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 4.08e-05 | 195 | 41 | 5 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 4.71e-05 | 201 | 41 | 5 | GO:0051170 | |
| GeneOntologyBiologicalProcess | RNA localization | 6.78e-05 | 217 | 41 | 5 | GO:0006403 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 7.50e-05 | 362 | 41 | 6 | GO:0034504 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 9.10e-05 | 231 | 41 | 5 | GO:0006109 | |
| GeneOntologyBiologicalProcess | protein folding | 1.22e-04 | 246 | 41 | 5 | GO:0006457 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 1.25e-04 | 247 | 41 | 5 | GO:0016051 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | 2.02e-04 | 434 | 41 | 6 | GO:0062012 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | 2.55e-04 | 646 | 41 | 7 | GO:0005975 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 7.87e-04 | 780 | 41 | 7 | GO:0042327 | |
| GeneOntologyBiologicalProcess | nuclear transport | 8.77e-04 | 378 | 41 | 5 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 8.77e-04 | 378 | 41 | 5 | GO:0006913 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.19e-03 | 405 | 41 | 5 | GO:0033674 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | 1.58e-03 | 879 | 41 | 7 | GO:0045937 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | 1.58e-03 | 879 | 41 | 7 | GO:0010562 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.82e-12 | 8 | 44 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 8.17e-12 | 10 | 44 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 6.45e-11 | 14 | 44 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.74e-10 | 18 | 44 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.95e-10 | 20 | 44 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 6.48e-10 | 21 | 44 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | inclusion body | 1.26e-06 | 90 | 44 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear pore | 2.23e-06 | 101 | 44 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear membrane | 7.67e-06 | 349 | 44 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | transferase complex | 1.49e-04 | 963 | 44 | 9 | GO:1990234 | |
| GeneOntologyCellularComponent | nuclear envelope | 1.55e-04 | 560 | 44 | 7 | GO:0005635 | |
| GeneOntologyCellularComponent | organelle envelope | RGPD1 RGPD4 QTRT2 RGPD2 RANBP2 ARL6IP6 CPT1A SLC25A16 RETSAT RGPD3 | 6.49e-04 | 1435 | 44 | 10 | GO:0031967 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 6.52e-04 | 934 | 44 | 8 | GO:0048471 | |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 4.78e-03 | 49 | 44 | 2 | GO:0090533 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 3.13e-10 | 16 | 35 | 5 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 4.63e-09 | 26 | 35 | 5 | MP:0012058 | |
| MousePheno | decreased tumor latency | 9.95e-09 | 30 | 35 | 5 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 1.18e-08 | 31 | 35 | 5 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 1.93e-08 | 34 | 35 | 5 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 3.96e-08 | 39 | 35 | 5 | MP:0012128 | |
| MousePheno | increased liver tumor incidence | 2.94e-07 | 111 | 35 | 6 | MP:0008019 | |
| MousePheno | increased hepatobiliary system tumor incidence | 2.94e-07 | 111 | 35 | 6 | MP:0010297 | |
| MousePheno | aneuploidy | 3.93e-07 | 61 | 35 | 5 | MP:0004024 | |
| MousePheno | abnormal rod electrophysiology | 4.45e-07 | 119 | 35 | 6 | MP:0004021 | |
| MousePheno | increased hepatocellular carcinoma incidence | 7.87e-07 | 70 | 35 | 5 | MP:0003331 | |
| MousePheno | increased lung carcinoma incidence | 1.35e-06 | 78 | 35 | 5 | MP:0008714 | |
| MousePheno | abnormal chromosome number | 2.20e-06 | 86 | 35 | 5 | MP:0004023 | |
| MousePheno | increased incidence of induced tumors | 3.97e-06 | 173 | 35 | 6 | MP:0002021 | |
| MousePheno | enlarged epididymis | 4.41e-06 | 99 | 35 | 5 | MP:0004931 | |
| MousePheno | increased tumor incidence | 4.42e-06 | 530 | 35 | 9 | MP:0002020 | |
| MousePheno | increased organ/body region tumor incidence | 4.56e-06 | 395 | 35 | 8 | MP:0010274 | |
| MousePheno | abnormal organ/body region tumor incidence | 5.10e-06 | 401 | 35 | 8 | MP:0013152 | |
| MousePheno | increased sarcoma incidence | 5.11e-06 | 102 | 35 | 5 | MP:0002032 | |
| MousePheno | increased lung tumor incidence | 6.47e-06 | 107 | 35 | 5 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 6.47e-06 | 107 | 35 | 5 | MP:0003694 | |
| MousePheno | increased respiratory system tumor incidence | 6.47e-06 | 107 | 35 | 5 | MP:0010298 | |
| MousePheno | abnormal blastocyst hatching | 8.45e-06 | 113 | 35 | 5 | MP:0003693 | |
| MousePheno | abnormal chromosome morphology | 1.44e-05 | 126 | 35 | 5 | MP:0003702 | |
| MousePheno | abnormal mitosis | 1.55e-05 | 128 | 35 | 5 | MP:0004046 | |
| MousePheno | abnormal tumor incidence | 1.90e-05 | 635 | 35 | 9 | MP:0002019 | |
| MousePheno | abnormal eye electrophysiology | 1.93e-05 | 228 | 35 | 6 | MP:0005551 | |
| MousePheno | small testis | 2.26e-05 | 823 | 35 | 10 | MP:0001147 | |
| MousePheno | abnormal tumor susceptibility | 2.29e-05 | 650 | 35 | 9 | MP:0002166 | |
| MousePheno | increased incidence of tumors by chemical induction | 2.47e-05 | 141 | 35 | 5 | MP:0004499 | |
| MousePheno | increased classified tumor incidence | 3.68e-05 | 381 | 35 | 7 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 3.87e-05 | 384 | 35 | 7 | MP:0020188 | |
| MousePheno | small gonad | 4.22e-05 | 885 | 35 | 10 | MP:0001116 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 4.54e-05 | 160 | 35 | 5 | MP:0005659 | |
| MousePheno | abnormal incidence of induced tumors | 4.88e-05 | 269 | 35 | 6 | MP:0013151 | |
| MousePheno | abnormal primary sex determination | 4.91e-05 | 901 | 35 | 10 | MP:0002211 | |
| MousePheno | abnormal epididymis size | 5.41e-05 | 166 | 35 | 5 | MP:0004926 | |
| MousePheno | abnormal testis size | 5.60e-05 | 915 | 35 | 10 | MP:0004849 | |
| MousePheno | abnormal preimplantation embryo development | 6.23e-05 | 171 | 35 | 5 | MP:0009781 | |
| MousePheno | neoplasm | 6.81e-05 | 747 | 35 | 9 | MP:0002006 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 6.85e-05 | 286 | 35 | 6 | MP:0008873 | |
| MousePheno | abnormal sex determination | 7.36e-05 | 945 | 35 | 10 | MP:0002210 | |
| MousePheno | abnormal cell nucleus morphology | 8.82e-05 | 184 | 35 | 5 | MP:0003111 | |
| MousePheno | decreased susceptibility to weight gain | 9.28e-05 | 186 | 35 | 5 | MP:0010182 | |
| MousePheno | increased energy expenditure | 1.19e-04 | 196 | 35 | 5 | MP:0004889 | |
| MousePheno | increased carcinoma incidence | 1.22e-04 | 197 | 35 | 5 | MP:0002038 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 1.40e-04 | 203 | 35 | 5 | MP:0011094 | |
| MousePheno | impaired glucose tolerance | 1.57e-04 | 480 | 35 | 7 | MP:0005293 | |
| MousePheno | abnormal male reproductive gland morphology | RGPD1 RGPD4 AP4E1 RGPD2 RANBP2 LIMK2 OTX2 CTSV TMEM86A ZNF541 RGPD3 | 2.06e-04 | 1290 | 35 | 11 | MP:0013325 |
| MousePheno | abnormal testis morphology | 2.25e-04 | 1081 | 35 | 10 | MP:0001146 | |
| MousePheno | abnormal lymph node medulla morphology | 2.71e-04 | 10 | 35 | 2 | MP:0002348 | |
| MousePheno | increased malignant tumor incidence | 2.88e-04 | 237 | 35 | 5 | MP:0002018 | |
| MousePheno | embryonic lethality before implantation | 3.17e-04 | 242 | 35 | 5 | MP:0006204 | |
| MousePheno | abnormal intracellular organelle morphology | 3.46e-04 | 546 | 35 | 7 | MP:0014239 | |
| MousePheno | abnormal internal male genitalia morphology | RGPD1 RGPD4 AP4E1 RGPD2 RANBP2 LIMK2 OTX2 CTSV TMEM86A ZNF541 RGPD3 | 4.01e-04 | 1392 | 35 | 11 | MP:0009205 |
| MousePheno | abnormal male genitalia morphology | RGPD1 RGPD4 AP4E1 RGPD2 RANBP2 LIMK2 OTX2 CTSV TMEM86A ZNF541 RGPD3 | 4.62e-04 | 1415 | 35 | 11 | MP:0009198 |
| MousePheno | abnormal male reproductive system morphology | RGPD1 RGPD4 AP4E1 RGPD2 RANBP2 LIMK2 OTX2 CTSV TMEM86A ZNF541 RGPD3 | 4.62e-04 | 1415 | 35 | 11 | MP:0001145 |
| MousePheno | aortic valve regurgitation | 4.67e-04 | 13 | 35 | 2 | MP:0006047 | |
| MousePheno | abnormal epididymis morphology | 5.14e-04 | 269 | 35 | 5 | MP:0002631 | |
| MousePheno | abnormal eye physiology | 6.47e-04 | 606 | 35 | 7 | MP:0005253 | |
| MousePheno | abnormal preimplantation embryo morphology | 6.48e-04 | 283 | 35 | 5 | MP:0014137 | |
| MousePheno | absent mandible | 8.09e-04 | 17 | 35 | 2 | MP:0000087 | |
| MousePheno | semilunar valve regurgitation | 9.09e-04 | 18 | 35 | 2 | MP:0006049 | |
| MousePheno | abnormal susceptibility to weight gain | 9.62e-04 | 309 | 35 | 5 | MP:0011117 | |
| MousePheno | abnormal energy expenditure | 1.02e-03 | 313 | 35 | 5 | MP:0005450 | |
| MousePheno | abnormal physiological response to xenobiotic | 1.09e-03 | 662 | 35 | 7 | MP:0008872 | |
| MousePheno | abnormal energy homeostasis | 1.16e-03 | 322 | 35 | 5 | MP:0005448 | |
| MousePheno | decreased CNS synapse formation | 1.36e-03 | 22 | 35 | 2 | MP:0004998 | |
| MousePheno | increased central memory CD4-positive, alpha-beta T cell number | 1.62e-03 | 24 | 35 | 2 | MP:0010841 | |
| MousePheno | abnormal cell cycle | 1.67e-03 | 520 | 35 | 6 | MP:0003077 | |
| MousePheno | increased susceptibility to Herpesvirales infection induced morbidity/mortality | 1.76e-03 | 25 | 35 | 2 | MP:0031026 | |
| MousePheno | increased spleen white pulp amount | 1.76e-03 | 25 | 35 | 2 | MP:0008478 | |
| MousePheno | cardiac valve regurgitation | 1.91e-03 | 26 | 35 | 2 | MP:0009384 | |
| MousePheno | agnathia | 2.06e-03 | 27 | 35 | 2 | MP:0030268 | |
| MousePheno | increased pre-B cell number | 2.37e-03 | 29 | 35 | 2 | MP:0003132 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell number | 2.54e-03 | 30 | 35 | 2 | MP:0012771 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell morphology | 2.54e-03 | 30 | 35 | 2 | MP:0010840 | |
| MousePheno | abnormal heart valve physiology | 2.54e-03 | 30 | 35 | 2 | MP:0011926 | |
| Domain | Ran_BP1 | 3.10e-11 | 12 | 41 | 5 | PF00638 | |
| Domain | RANBD1 | 3.10e-11 | 12 | 41 | 5 | PS50196 | |
| Domain | RanBD | 5.03e-11 | 13 | 41 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 5.03e-11 | 13 | 41 | 5 | IPR000156 | |
| Domain | GCC2_Rab_bind | 6.96e-10 | 7 | 41 | 4 | IPR032023 | |
| Domain | Rab_bind | 6.96e-10 | 7 | 41 | 4 | PF16704 | |
| Domain | - | 4.16e-09 | 10 | 41 | 4 | 1.10.220.60 | |
| Domain | GRIP | 6.52e-09 | 11 | 41 | 4 | PF01465 | |
| Domain | Grip | 6.52e-09 | 11 | 41 | 4 | SM00755 | |
| Domain | GRIP_dom | 9.77e-09 | 12 | 41 | 4 | IPR000237 | |
| Domain | GRIP | 9.77e-09 | 12 | 41 | 4 | PS50913 | |
| Domain | TPR | 8.93e-06 | 129 | 41 | 5 | SM00028 | |
| Domain | TPR_repeat | 1.04e-05 | 133 | 41 | 5 | IPR019734 | |
| Domain | TPR-contain_dom | 1.86e-05 | 150 | 41 | 5 | IPR013026 | |
| Domain | TPR | 2.93e-05 | 165 | 41 | 5 | PS50005 | |
| Domain | TPR_REGION | 2.93e-05 | 165 | 41 | 5 | PS50293 | |
| Domain | - | 8.63e-05 | 207 | 41 | 5 | 1.25.40.10 | |
| Domain | TPR-like_helical_dom | 1.50e-04 | 233 | 41 | 5 | IPR011990 | |
| Domain | - | 1.58e-03 | 391 | 41 | 5 | 2.30.29.30 | |
| Domain | PH_dom-like | 2.30e-03 | 426 | 41 | 5 | IPR011993 | |
| Domain | Znf_CCCH | 7.19e-03 | 58 | 41 | 2 | IPR000571 | |
| Domain | ZF_C3H1 | 7.19e-03 | 58 | 41 | 2 | PS50103 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 4.29e-10 | 18 | 33 | 5 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.18e-08 | 40 | 33 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.61e-08 | 41 | 33 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 4.10e-08 | 42 | 33 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.63e-08 | 43 | 33 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 7.32e-08 | 47 | 33 | 5 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 9.08e-08 | 49 | 33 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.01e-07 | 50 | 33 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.11e-07 | 51 | 33 | 5 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.64e-07 | 55 | 33 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.15e-07 | 58 | 33 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.15e-07 | 58 | 33 | 5 | MM14736 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.65e-07 | 117 | 33 | 6 | MM15387 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.83e-07 | 65 | 33 | 5 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 6.87e-07 | 73 | 33 | 5 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.23e-06 | 82 | 33 | 5 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.39e-06 | 84 | 33 | 5 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.56e-06 | 86 | 33 | 5 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.18e-06 | 92 | 33 | 5 | MM14951 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 3.29e-06 | 100 | 33 | 5 | MM14561 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 4.96e-06 | 193 | 33 | 6 | MM14890 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 6.27e-06 | 114 | 33 | 5 | MM15361 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.15e-05 | 129 | 33 | 5 | MM14894 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.49e-05 | 234 | 33 | 6 | MM14898 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.77e-05 | 141 | 33 | 5 | MM15266 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 3.42e-05 | 271 | 33 | 6 | MM15388 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.42e-05 | 271 | 33 | 6 | MM15406 | |
| Pathway | REACTOME_SUMOYLATION | 4.22e-05 | 169 | 33 | 5 | MM14919 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 9.84e-05 | 202 | 33 | 5 | MM15362 | |
| Pathway | REACTOME_M_PHASE | 2.43e-04 | 387 | 33 | 6 | MM15364 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 3.03e-04 | 257 | 33 | 5 | MM14755 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 4.27e-04 | 277 | 33 | 5 | MM15414 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 9.96e-04 | 505 | 33 | 6 | MM15548 | |
| Pathway | REACTOME_CELL_CYCLE | 2.47e-03 | 603 | 33 | 6 | MM14635 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 2.66e-03 | 612 | 33 | 6 | MM15547 | |
| Pathway | KEGG_LYSOSOME | 2.79e-03 | 121 | 33 | 3 | M11266 | |
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 30944974 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 38838144 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 21205196 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 18949001 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 25187515 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 9037092 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 23536549 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 8603673 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 4.76e-14 | 7 | 43 | 5 | 7559465 | |
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 26632511 | ||
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 4.76e-14 | 7 | 43 | 5 | 17372272 | |
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 24403063 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 23818861 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 38657106 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.76e-14 | 7 | 43 | 5 | 11353387 | |
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 12191015 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 22821000 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.27e-13 | 8 | 43 | 5 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.27e-13 | 8 | 43 | 5 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.27e-13 | 8 | 43 | 5 | 28745977 | |
| Pubmed | 1.27e-13 | 8 | 43 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.27e-13 | 8 | 43 | 5 | 21310149 | |
| Pubmed | 2.85e-13 | 9 | 43 | 5 | 9733766 | ||
| Pubmed | 2.85e-13 | 9 | 43 | 5 | 28100513 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.85e-13 | 9 | 43 | 5 | 18394993 | |
| Pubmed | 2.85e-13 | 9 | 43 | 5 | 28877029 | ||
| Pubmed | 2.85e-13 | 9 | 43 | 5 | 11553612 | ||
| Pubmed | 2.85e-13 | 9 | 43 | 5 | 17887960 | ||
| Pubmed | 2.85e-13 | 9 | 43 | 5 | 10601307 | ||
| Pubmed | 5.70e-13 | 10 | 43 | 5 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 5.70e-13 | 10 | 43 | 5 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 5.70e-13 | 10 | 43 | 5 | 8857542 | |
| Pubmed | 5.70e-13 | 10 | 43 | 5 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.04e-12 | 11 | 43 | 5 | 35771867 | |
| Pubmed | 1.04e-12 | 11 | 43 | 5 | 17069463 | ||
| Pubmed | 1.04e-12 | 11 | 43 | 5 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.90e-12 | 13 | 43 | 5 | 31427429 | |
| Pubmed | 6.76e-12 | 15 | 43 | 5 | 14697343 | ||
| Pubmed | 5.89e-11 | 22 | 43 | 5 | 27717094 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 7.07e-11 | 7 | 43 | 4 | 15710750 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.11e-09 | 38 | 43 | 5 | 12791264 | |
| Pubmed | 7.35e-08 | 86 | 43 | 5 | 37253089 | ||
| Pubmed | 1.49e-07 | 99 | 43 | 5 | 27746211 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 3.38e-07 | 370 | 43 | 7 | 22922362 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 6.99e-07 | 135 | 43 | 5 | 31077711 | |
| Pubmed | 7.65e-07 | 418 | 43 | 7 | 34709266 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.03e-06 | 146 | 43 | 5 | 23892456 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.30e-06 | 153 | 43 | 5 | 26365490 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 9155026 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 31558666 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 31151137 | ||
| Pubmed | A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS. | 1.49e-06 | 2 | 43 | 2 | 34155405 | |
| Pubmed | Impaired tissue homing by the Ikzf3N159S variant is mediated by interfering with Ikaros function. | 1.49e-06 | 2 | 43 | 2 | 37662955 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 33182226 | ||
| Pubmed | Critical function of Ikaros in controlling Aiolos gene expression. | 1.49e-06 | 2 | 43 | 2 | 17383641 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 27881177 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24509510 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 33499314 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 2.04e-06 | 701 | 43 | 8 | 30196744 | |
| Pubmed | Analysis of Ikaros family splicing variants in human hematopoietic lineages. | 4.48e-06 | 3 | 43 | 2 | 20432734 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 27502439 | ||
| Pubmed | The CD8alpha gene locus is regulated by the Ikaros family of proteins. | 4.48e-06 | 3 | 43 | 2 | 12504015 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 11937265 | ||
| Pubmed | Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. | 4.48e-06 | 3 | 43 | 2 | 9560339 | |
| Pubmed | Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma. | 4.48e-06 | 3 | 43 | 2 | 18332232 | |
| Pubmed | 6.85e-06 | 215 | 43 | 5 | 35973513 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 8.72e-06 | 226 | 43 | 5 | 37839992 | |
| Pubmed | The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. | 8.94e-06 | 4 | 43 | 2 | 24292623 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 24328678 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 9.70e-06 | 231 | 43 | 5 | 16452087 | |
| Pubmed | Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities. | 1.49e-05 | 5 | 43 | 2 | 10978333 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 10766745 | ||
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 1.67e-05 | 442 | 43 | 6 | 15815621 | |
| Pubmed | 1.99e-05 | 129 | 43 | 4 | 23022380 | ||
| Pubmed | Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. | 2.23e-05 | 6 | 43 | 2 | 20566697 | |
| Pubmed | Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cells. | 3.12e-05 | 7 | 43 | 2 | 26823144 | |
| Pubmed | Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. | 3.12e-05 | 7 | 43 | 2 | 10357820 | |
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 19734904 | ||
| Pubmed | 6.68e-05 | 10 | 43 | 2 | 20541250 | ||
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 8.15e-05 | 11 | 43 | 2 | 10204490 | |
| Pubmed | 9.78e-05 | 12 | 43 | 2 | 9096102 | ||
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 1.20e-04 | 392 | 43 | 5 | 33144569 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 1.34e-04 | 1257 | 43 | 8 | 37317656 | |
| Pubmed | A molecular dissection of the repression circuitry of Ikaros. | 1.35e-04 | 14 | 43 | 2 | 12015313 | |
| Pubmed | Ikaros family proteins redundantly regulate temporal patterning in the developing mouse retina. | 1.35e-04 | 14 | 43 | 2 | 36537580 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 1.37e-04 | 647 | 43 | 6 | 26618866 | |
| Pubmed | A conserved regulatory logic controls temporal identity in mouse neural progenitors. | 1.55e-04 | 15 | 43 | 2 | 25654255 | |
| Pubmed | 1.65e-04 | 963 | 43 | 7 | 28671696 | ||
| Pubmed | RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation. | 1.77e-04 | 16 | 43 | 2 | 30760870 | |
| Pubmed | AirID, a novel proximity biotinylation enzyme, for analysis of protein-protein interactions. | 2.01e-04 | 17 | 43 | 2 | 32391793 | |
| Pubmed | 2.01e-04 | 17 | 43 | 2 | 15767674 | ||
| Pubmed | Ikaros promotes early-born neuronal fates in the cerebral cortex. | 2.52e-04 | 19 | 43 | 2 | 23382203 | |
| Pubmed | 3.13e-04 | 263 | 43 | 4 | 34702444 | ||
| Pubmed | 3.39e-04 | 1084 | 43 | 7 | 11544199 | ||
| Pubmed | 3.40e-04 | 1442 | 43 | 8 | 35575683 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 3.50e-04 | 271 | 43 | 4 | 32433965 | |
| Pubmed | 4.76e-04 | 26 | 43 | 2 | 32071204 | ||
| Pubmed | 5.69e-04 | 844 | 43 | 6 | 25963833 | ||
| Pubmed | Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. | 6.35e-04 | 30 | 43 | 2 | 24292625 | |
| Interaction | RGPD4 interactions | 6.11e-10 | 22 | 40 | 5 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 1.86e-09 | 27 | 40 | 5 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 3.43e-08 | 47 | 40 | 5 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 4.25e-08 | 49 | 40 | 5 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 3.46e-07 | 74 | 40 | 5 | int:RGPD8 | |
| Interaction | RGPD5 interactions | 1.27e-06 | 96 | 40 | 5 | int:RGPD5 | |
| Interaction | ICOSLG interactions | 8.07e-06 | 20 | 40 | 3 | int:ICOSLG | |
| Cytoband | 2p11.2 | 3.28e-05 | 64 | 44 | 3 | 2p11.2 | |
| Cytoband | 2q12.3 | 1.21e-04 | 17 | 44 | 2 | 2q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 1.13e-03 | 213 | 44 | 3 | chr2p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 1.48e-03 | 59 | 44 | 2 | chr2q13 | |
| Cytoband | 17q21 | 1.69e-03 | 63 | 44 | 2 | 17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q12 | 2.84e-03 | 82 | 44 | 2 | chr2q12 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.64e-07 | 115 | 26 | 5 | 769 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 6.80e-11 | 43 | 42 | 6 | MM3857 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.90e-09 | 33 | 42 | 5 | MM477 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 9.44e-06 | 474 | 42 | 7 | M40991 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 6.39e-05 | 435 | 42 | 6 | MM1221 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D | 7.14e-05 | 888 | 42 | 8 | MM1315 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Mesoderm Day 15-Confounder_removed-fold2.0_adjp0.05 | RGPD4 GMPR ARL6IP6 OTX2 PAN3 SLC35F3 FAM20A KIF26A CTSV GRK6 RGPD3 | 2.10e-05 | 1276 | 41 | 11 | PCBC_ratio_MESO-5_vs_MESO-15_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | RGPD4 AMFR GMPR TBC1D9B ARL6IP6 OTX2 SLC35F3 FAM20A CTSV RGPD3 | 5.13e-05 | 1153 | 41 | 10 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 8.30e-07 | 176 | 44 | 5 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-05 | 147 | 44 | 4 | 3ed5b020ce1f1277917d79ef1f7da53fa474e8db | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-05 | 153 | 44 | 4 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.69e-05 | 156 | 44 | 4 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 165 | 44 | 4 | 7039bb5a7af4684fbd1192230864e5cd6936e83c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 165 | 44 | 4 | d2c79653710b139794170f3d72f11392fc548ac7 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 2.27e-05 | 168 | 44 | 4 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 170 | 44 | 4 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-05 | 171 | 44 | 4 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 176 | 44 | 4 | d0a3e176df1270968efa79c00dc941c5e1c4f7aa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 176 | 44 | 4 | 274458d80f9f3f080248cbf64e4784ef351e7254 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 2.78e-05 | 177 | 44 | 4 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 177 | 44 | 4 | b07e6139618d888a9fd7cf43cad0d86a3f63e09e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 177 | 44 | 4 | 6376ec12322c04d5d37ec2fdc376700464cbc7fb | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.78e-05 | 177 | 44 | 4 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-05 | 179 | 44 | 4 | 31411780f1a44bf2d102f288416e97eacec4b6b6 | |
| ToppCell | COVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type | 2.97e-05 | 180 | 44 | 4 | 5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.97e-05 | 180 | 44 | 4 | 702673c0b7c5b0d22a6af3884374804b8c4d6254 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 180 | 44 | 4 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 184 | 44 | 4 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.30e-05 | 185 | 44 | 4 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.37e-05 | 186 | 44 | 4 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-05 | 187 | 44 | 4 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-05 | 187 | 44 | 4 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 3.44e-05 | 187 | 44 | 4 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | background-B_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.52e-05 | 188 | 44 | 4 | 9acb7a95e3095f15918a5d094107d1d565a42842 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.67e-05 | 190 | 44 | 4 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-05 | 192 | 44 | 4 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.82e-05 | 192 | 44 | 4 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-05 | 192 | 44 | 4 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.14e-05 | 196 | 44 | 4 | fc67d8aad1ec4d7f98ffe44fb103e230b9b42c35 | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.22e-05 | 197 | 44 | 4 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-05 | 197 | 44 | 4 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-05 | 197 | 44 | 4 | 749e0e332644543cbdf2ee38c2b301ce0a019a7f | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-05 | 199 | 44 | 4 | 1bb02f41f3cc76a28581e38b0ca4c36b930b85b4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-05 | 200 | 44 | 4 | fe22f7c97f4e37dfa7881d0f1d9245c1237d873b | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-04 | 118 | 44 | 3 | 6053e19d040fb394f9c270361af07b0c5a4d47db | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-04 | 118 | 44 | 3 | 811e8521129914eef46785a4227c1860e77d9096 | |
| ToppCell | Mild/Remission-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.32e-04 | 121 | 44 | 3 | 68940a552233d255b90ce5a081339c0d9d46ab02 | |
| ToppCell | COVID-19-B_cells-B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.86e-04 | 130 | 44 | 3 | 267b06a0db31e2664cf595cd737402da07ab51cd | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-04 | 131 | 44 | 3 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-04 | 139 | 44 | 3 | ecc2a6ecc27748c50885cd4f0ad8a8cd1252aee6 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.78e-04 | 143 | 44 | 3 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 150 | 44 | 3 | 17da17f01a3d41ac7df20f806e3eae30eca06982 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 150 | 44 | 3 | 8b781ec3e6c2adf052d46d724e2aef72b0c27d13 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 150 | 44 | 3 | 8702d5bb419d5e997d388e8f7e0365ba5d1de8d5 | |
| ToppCell | Int-URO-Other|Int-URO / Disease, Lineage and Cell Type | 4.44e-04 | 151 | 44 | 3 | ea5f25842e621be41a6491c9959d419d9cc7ebd6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-04 | 151 | 44 | 3 | 10da94037225a71844281ddcb395072250a78094 | |
| ToppCell | Int-URO-Other-RBC|Int-URO / Disease, Lineage and Cell Type | 4.44e-04 | 151 | 44 | 3 | 0344d482f1c55c9eaa15beb8d6bac1c6cdca21b3 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.61e-04 | 153 | 44 | 3 | 95b28c5bd10ffb74c0993ebd565038b9818e4bd2 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.61e-04 | 153 | 44 | 3 | c4dcdcaa672929c1da870e9fb8ada1bb030ad12f | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.61e-04 | 153 | 44 | 3 | b09f8def40a1ea56722f3398f61a036667b61cd9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.61e-04 | 153 | 44 | 3 | 3ab9d55b3db51715c1d61eca142384195ce4b54f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-04 | 154 | 44 | 3 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | Adult-Immune-B_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.79e-04 | 155 | 44 | 3 | 5857aebd43b901fc9f8c46f2d628582969db9e6a | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.88e-04 | 156 | 44 | 3 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.97e-04 | 157 | 44 | 3 | 803af734d7f775d294391e2b84e472a732e18cef | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.97e-04 | 157 | 44 | 3 | 9aa5304a9704da6dd4eda7d6940494b00e38b2e8 | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.97e-04 | 157 | 44 | 3 | 0551442ae14685d8fe5729e3960c6324b1e05e4d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-04 | 158 | 44 | 3 | 2cfa6dd36c8ae534cf1dd49366d4b4433388c1e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-04 | 158 | 44 | 3 | 0c9bb7f8d080a052ca71701544a076c6c2ea67cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-04 | 158 | 44 | 3 | cebb58878b6945074bc1c7d5848d842da5dcbae1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.16e-04 | 159 | 44 | 3 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.16e-04 | 159 | 44 | 3 | 6115cb03c2ad08e4c1b65893d522f685ff0bc692 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.16e-04 | 159 | 44 | 3 | 95834b767cfb4fb8c5aeea89c10f3e14a1fd15c1 | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.25e-04 | 160 | 44 | 3 | e4516b093003275084fc327d1597394a436754eb | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.25e-04 | 160 | 44 | 3 | a90eb621481fd07a821495db07d1032e109fd386 | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.25e-04 | 160 | 44 | 3 | 0a507e3d59d7f744d0201a531ea84fa97a68aedb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.35e-04 | 161 | 44 | 3 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-04 | 162 | 44 | 3 | 66069146e2666d13c594bd76247893354a697c5d | |
| ToppCell | Adult-Immune-B_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.54e-04 | 163 | 44 | 3 | 4f5821299b265663c7d0352b28285f56e1988841 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-04 | 164 | 44 | 3 | e9e5a1462d8ed60b2e5bf603c8c47eb85bce83d5 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-04 | 164 | 44 | 3 | 1a9b444d2c6abcc83d4355ec5228b27541df2bd0 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.74e-04 | 165 | 44 | 3 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-04 | 165 | 44 | 3 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-04 | 165 | 44 | 3 | 7e7643834ed483aec04f513cca38d6367fda9ff8 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 166 | 44 | 3 | 0b7503e27e26dcbf7f1b893c32ce0b21ce58bd4a | |
| ToppCell | Adult-Immune-natural_killer_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.95e-04 | 167 | 44 | 3 | ff1ce3b1a2d91d2ad979f25899db4f4eeb865892 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 167 | 44 | 3 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-04 | 168 | 44 | 3 | 784ce773521e5d74570f45120e56d112bc76ff49 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.16e-04 | 169 | 44 | 3 | 203971cceeba150d0e8891c92662545e84c77837 | |
| ToppCell | Severe-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass | 6.26e-04 | 170 | 44 | 3 | 5788e1158fde036937d41708e9db3222ca351eb1 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.26e-04 | 170 | 44 | 3 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 170 | 44 | 3 | 7a4ed69c807c3761210776e8fe6680d1bd892e82 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-04 | 171 | 44 | 3 | 55b194a9bf4d3e4b5d96e0d1298424359c441cbb | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 6.37e-04 | 171 | 44 | 3 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.37e-04 | 171 | 44 | 3 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.37e-04 | 171 | 44 | 3 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | COVID-19-kidney-Plasma|kidney / Disease (COVID-19 only), tissue and cell type | 6.37e-04 | 171 | 44 | 3 | a59a054b8e119215f24dc5c80ad5a8094b3500f9 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-04 | 171 | 44 | 3 | c6fc9ef9735dbf5314a4c7dac2b2954b0985ae4d | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.37e-04 | 171 | 44 | 3 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.37e-04 | 171 | 44 | 3 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 6.48e-04 | 172 | 44 | 3 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-04 | 173 | 44 | 3 | 62ba49c1c16760a8c6cde0cc44e068f94386946a | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-04 | 174 | 44 | 3 | 01eff218e71a04201189a0313aaf91437fffed95 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-04 | 174 | 44 | 3 | f0f6d135e1fb4c15022be103b00d8d5456515a18 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-04 | 174 | 44 | 3 | 1b2a2129c08bac01fc638692313b196759a1e0d7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-04 | 174 | 44 | 3 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-04 | 174 | 44 | 3 | 2f4bc0275cbcaa830d04a4c76e042456908d2277 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-04 | 174 | 44 | 3 | 5bde24eb588dc588efc413811379548120ec0c7f | |
| Disease | alcohol and nicotine codependence | 1.25e-04 | 13 | 38 | 2 | EFO_0004776 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 1.68e-04 | 15 | 38 | 2 | C2930967 | |
| Disease | eosinophil percentage of granulocytes | 2.30e-04 | 234 | 38 | 4 | EFO_0007996 | |
| Disease | taurine measurement | 5.15e-04 | 26 | 38 | 2 | EFO_0010536 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 1.90e-03 | 50 | 38 | 2 | C0023453 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 2.06e-03 | 52 | 38 | 2 | C0023452 | |
| Disease | asthma | 2.64e-03 | 751 | 38 | 5 | MONDO_0004979 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2.82e-03 | 61 | 38 | 2 | C1961102 | |
| Disease | neutrophil percentage of granulocytes | 3.15e-03 | 228 | 38 | 3 | EFO_0007994 | |
| Disease | histidine measurement | 3.29e-03 | 66 | 38 | 2 | EFO_0009769 | |
| Disease | basophil count, eosinophil count | 3.68e-03 | 241 | 38 | 3 | EFO_0004842, EFO_0005090 | |
| Disease | Cleft palate | 3.79e-03 | 71 | 38 | 2 | HP_0000175 | |
| Disease | otosclerosis | 4.91e-03 | 81 | 38 | 2 | EFO_0004213 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MGHNFGMFHDDYSCK | 341 | Q9UKQ2 | |
| YSQGKHGFTMAMNAF | 66 | O60911 | |
| SYHGWMFTEHGKMSR | 131 | P50416 | |
| GNLTGFISYHMMDTH | 1001 | Q9UPM8 | |
| LTMRDTMKYVYGHHG | 281 | P16260 | |
| TFLEMKGHFYMHAGS | 281 | P49792 | |
| KGHFYMHAGSLLLKM | 286 | P49792 | |
| FLHMKTGGEMNYGFH | 1541 | Q9H1A4 | |
| FAHGDIYAYMEKSGM | 96 | Q15842 | |
| FAKGIASGMAYLHSM | 431 | P53671 | |
| FSFGHMSLGKSYTMI | 466 | Q9ULI4 | |
| MMGFAGIHEAHLLFF | 16 | Q8NGQ2 | |
| MYTIHMGCHGFRDPF | 476 | Q13422 | |
| FLHQVGGHMSVMKYD | 21 | Q96PC2 | |
| SVMHFGMSGFDAHTL | 106 | A0A2R8Y4Y8 | |
| VFAYDFHAGGETMMS | 566 | Q58A45 | |
| GVLLMMHNFEHYFGF | 376 | Q9H974 | |
| ATFLEMKGHFYMHAG | 281 | A6NKT7 | |
| MKGHFYMHAGSLLLK | 286 | A6NKT7 | |
| DIHAHSTMMNGFMYG | 326 | Q5VU57 | |
| DFHSATMLGSHMYVF | 181 | Q9BQ90 | |
| HSLYGGYMMSHQFSS | 911 | A0A0U1RQI7 | |
| TNFGFMNGAMHFHDY | 321 | Q8IW92 | |
| MNGAMHFHDYKSDVT | 326 | Q8IW92 | |
| FYGMSSDTAMNKHAG | 266 | P36959 | |
| HFHYVLSMGAVFAIM | 376 | P00395 | |
| MNGGDLKFHIYHMGQ | 266 | P43250 | |
| FLDYVMFTIHMGCHG | 461 | Q9UKT9 | |
| MGMSKSHSFFGYPLS | 1 | P46059 | |
| SATFLEMKGHFYMHA | 271 | P0DJD0 | |
| EMKGHFYMHAGSLLL | 276 | P0DJD0 | |
| FYMHAGSLLLKMGQH | 281 | P0DJD0 | |
| FGGMDCGSYLTPMHH | 196 | P32243 | |
| SMHALLVNHYMKGGF | 276 | Q6NUM9 | |
| ATFLEMKGHFYMHAG | 281 | Q7Z3J3 | |
| MKGHFYMHAGSLLLK | 286 | Q7Z3J3 | |
| MMEAHFKYHGNLTGR | 1 | A0A1B0GWG4 | |
| VIAHCGMHYFMGKSK | 501 | A2VDJ0 | |
| TFLEMKGHFYMHAGS | 281 | P0DJD1 | |
| KGHFYMHAGSLLLKM | 286 | P0DJD1 | |
| IGNMDRHHYEMFTKF | 406 | Q96MK3 | |
| AGIVMMTYADGFHSH | 216 | Q8IY50 | |
| FKEFVTGMSGMYHGD | 901 | Q66K14 | |
| ITGYTHGMHTLAFMA | 206 | Q9UKV5 | |
| KKLTGHSFHMGYSMA | 196 | Q8N6S5 | |
| HSFHMGYSMAILNGI | 201 | Q8N6S5 | |
| GYFVHGLLMFAVTHM | 91 | Q8N2M4 | |
| KFESMGDHGYYSMLG | 536 | Q5HYM0 | |
| VHHVMAMGAFFSGIF | 116 | Q96CP7 | |
| MFGDFGHGILMTLFA | 406 | Q93050 | |
| GTMFDFFTHMHNKKH | 1076 | Q5VUA4 | |
| MFYTEKGLSSHMCFH | 846 | Q9H0D2 | |
| MAAMFAIYHGSHGLE | 391 | P23378 |